Skip to main content
SpringerLink
Log in

An American View of BCG Vaccination

  • Chapter
Bedeutung und Stand der BCG-Schutzimpfung gegen die Tuberkulose

Part of the book series: Die Tuberkulose und ihre Grenzgebiete in Einzeldarstellungen ((TBC,volume 18))

  • 14 Accesses

Abstract

The United States is one of the few countries in the world in which BCG has not been used extensively for the control of tuberculosis. A brief review of recent history may help those in other countries to understand the factors which initially kept the United States from adopting BCG and the additional factors which make it even less likely now.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Palmer, C. E., L. W. Shaw, and G. W. Comstock: Community trials of BCG vaccination. Amer. Rev. Tuberc. 77, 877 (1958).

    CAS  Google Scholar 

  2. Comstock, G. W., and C. E. Palmer: Long-term-results of BCG vaccination in the southern United States. Amer. Rev. resp. Dis. (In press.).

    Google Scholar 

  3. Medical Research Council: B.C.G. and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Third Report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee, B.M.J., April 13, 1963, i. 973-978.

    Google Scholar 

  4. Palmer, C. E.: Symposium on the value of tuberculin reactions for the selection of cases for BCG vaccination and significance of post-vaccination allergy. Bull. IUAT, Jan.–Apr. 1957, 27(1-2), 106–119.

    Google Scholar 

  5. —, and L. B. Edwards: Sensitivity to mycobacterial PPD antigens with some laboratory evidence of its significance. Tuberkulozo. (In press.)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tuberculosis Program, 81 Woodmont Avenue, Bethesda, Md., 20014, USA

    Shirley H. Ferebee & Carroll E. Palmer

  2. Research Section, Tuberculosis Program, Communicable Disease Center, Public Health Service, United States Department of Health, Education, and Welfare, Bethesda, Maryland, USA

    Carroll E. Palmer

Authors
  1. Shirley H. Ferebee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carroll E. Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zürcher kantonalen Liga gegen die Tuberkulose, 8636, Wald, Schweiz

    E. Haefliger (Präsident) (Präsident)

Rights and permissions

Reprints and permissions

Copyright information

© 1966 Springer-Verlag, Berlin · Heidelberg

About this chapter

Cite this chapter

Ferebee, S.H., Palmer, C.E. (1966). An American View of BCG Vaccination. In: Haefliger, E. (eds) Bedeutung und Stand der BCG-Schutzimpfung gegen die Tuberkulose. Die Tuberkulose und ihre Grenzgebiete in Einzeldarstellungen, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85731-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85731-7_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85732-4

  • Online ISBN: 978-3-642-85731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation